(19)
(11) EP 1 576 098 A2

(12)

(43) Date of publication:
21.09.2005 Bulletin 2005/38

(21) Application number: 03727809.0

(22) Date of filing: 26.05.2003
(51) International Patent Classification (IPC)7C12N 1/00
(86) International application number:
PCT/IB2003/002256
(87) International publication number:
WO 2003/102130 (11.12.2003 Gazette 2003/50)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 04.06.2002 US 386156 P

(71) Applicant: Pfizer Products Inc.
Connecticut 06340 (US)

(72) Inventors:
  • BUCKBINDER,LeonardPfizer Global Research and Dev.
    Groton, CT 06430 (US)
  • SCHAEFER,Jean,FrancesPfizer Global Research & Dev
    Groton, CT 06340 (US)

(74) Representative: Boxall, Sarah Jane et al
Pfizer Limited European Pharma Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) A HUMAN CELL ASSAY TO DETERMINE EFFECT OF SAMPLE COMPOUNDS ON COL2 ENHANCER EXPRESSION